Showing results (131-140 of 184) with videos related to
Sort By:
Pageof 19
Gastroenterology|June 16, 2010
Variants in the ITPA gene protect against ribavirin-induced hemolytic anemia and decrease the need for ribavirin dose reductionAlexander J Thompson, Jacques Fellay, Keyur Patel, et al.Nature|August 18, 2009
Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearanceDongliang Ge, Jacques Fellay, Alexander J Thompson, et al.Journal of Gastroenterology and Hepatology|March 18, 2015
Non-cirrhotic thrombocytopenic patients with hepatitis C virus: Characteristics and outcome of antiviral therapyEdoardo G Giannini, Nezam H Afdhal, Samuel H Sigal, et al.Hepatology Communications|August 28, 2023
Parental leave, childcare policies, and workplace bias for hepatology professionals: A national surveyLauren D Feld, Monika Sarkar, Jennifer S Au, et al.Journal of Hepatology|September 15, 2014
Safety profile of boceprevir and telaprevir in chronic hepatitis C: real world experience from HCV-TARGETStuart C Gordon, Andrew J Muir, Joseph K Lim, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 7, 2022
Safety and Sustained Efficacy of the Farnesoid X Receptor (FXR) Agonist Cilofexor Over a 96-Week Open-label Extension in Patients With PSCMichael Trauner, Christopher L Bowlus, Aliya Gulamhusein, et al.The American Journal of Gastroenterology|August 30, 2019
Patients With Nonalcoholic Steatohepatitis Experience Severe Impairment of Health-Related Quality of LifeZobair M Younossi, Maria Stepanova, Eric J Lawitz, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 4, 2019
Long-term Benefits of Sustained Virologic Response for Patient-Reported Outcomes in Patients With Chronic Hepatitis C Virus InfectionZobair M Younossi, Maria Stepanova, Andrei Racila, et al.Contemporary Clinical Trials|July 15, 2018
The Hepatitis C-Alcohol Reduction Treatment (Hep ART) intervention: Study protocol of a multi-center randomized controlled trialRae Jean Proeschold-Bell, Donna M Evon, Christina Makarushka, et al.Hepatology (Baltimore, Md.)|September 25, 2014
Cardiac dysfunction associated with a nucleotide polymerase inhibitor for treatment of hepatitis CTariq Ahmad, Philip Yin, Jeffrey Saffitz, et al.Pageof 19